价格

1-f

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

显示相关度最高的 100 个专利族。

CRYSTALLINE FORMS OF (S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1-METHYL-1H-PYRAZOL-4-YL)PYRROLO[2,1-F][1,2,4]TRIAZIN-4-YL)PIPERAZINYL)-PYRIMIDIN-5-YL)ETHAN-1-AMINE AND METHODS OF MAKING
EP 4302761 A3申请人: BLUEPRINT MEDICINES CORP优先权: 2019
EP
US
WO
12 件公开
Reversible covalent linkage of functional molecules
EP 2889624 B1申请人: UCL BUSINESS PLC优先权: 2009
CN
EP
US
9 件公开
1,4-DIHYDROBENZO[D]PYRAZOLO[3,4-F][1,3]DIAZEPINE DERIVATIVES AND RELATED COMPOUNDS AS LRRK2, NUAK1 AND/OR TYK2 KINASE MODULATORS FOR THE TREATMENT OF E.G. AUTOIMMUNE DISEASE
EP 4028016 A1申请人: ORIGENIS GMBH优先权: 2019
CN
EP
US
WO
6 件公开
Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as TLR7 agonist
US 12281119 B2申请人: BEIGENE LTD优先权: 2019
EP
US
WO
6 件公开
COMPOUND SUITABLE FOR DETECTION OF VESICULAR ACETYLCHOLINE TRANSPORTER
EP 2982671 B1申请人: HAMAMATSU PHOTONICS KK优先权: 2013
CN
EP
US
WO
5 件公开
TERT-BUTYL (S)-2-(4-(PHENYL)-6H-THIENO[3, 2-F][1, 2, 4]TRIAZOLO[4, 3-A] [1,4]DIAZEPIN-6-YL) ACETATE DERIVATIVES AND RELATED COMPOUNDS AS BROMODOMAIN BRD4 INHIBITORS FOR TREATING CANCER
US 2021221821 A1申请人: GENENTECH INC优先权: 2018
CN
US
WO
5 件公开
POLYMORPHS OF 2-(4-(2-(1-ISOPROPYL-3-METHYL-1H-1,2,4-TRIAZOL-5-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPIN-9-YL)-1H-PYRAZOL-1-YL)-2-METHYLPROPANAMIDE, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF
US 2015166570 A1申请人: GENENTECH INC优先权: 2013
CN
US
5 件公开
CRYSTALLINE FORM OF (3S,7S,10R,13R)-13-BENZYL-20-FLUORO-7-ISOBUTYL-N-(2-(3-METHOXY-1,2,4-OXADIAZOL-5-YL)ETHYL)-6,9-DIMETHYL-1,5,8,11-TETRAOXO-10-(2,2,2-TRIFLUOROETHYL)-1,2,3,4,5,6,7,8,9,10,11,12,13,14-TETRADECAHYDRO-[1]OXA[4,7,10,14]TETRAAZACYCLOHEPTADECINO[16,17-F]QUINOLINE-3-CARBOXAMIDE
EP 4587444 A1申请人: IDORSIA PHARMACEUTICALS LTD优先权: 2022
CN
EP
US
WO
4 件公开
Crystalline forms of [(1R), 2S]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester
US 2007088035 A1申请人: BRISTOL MYERS SQUIBB CO优先权: 2006
CN
US
4 件公开
Dibenzo[b,f][1,4]oxazapine compounds
US 8093237 B2申请人: BECKER CYRUS优先权: 2008
CN
US
4 件公开

药物